These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23228010)

  • 1. Design, synthesis, and antibacterial activities of conformationally constrained kanamycin A derivatives.
    Zhang W; Chen Y; Liang Q; Li H; Jin H; Zhang L; Meng X; Li Z
    J Org Chem; 2013 Jan; 78(2):400-9. PubMed ID: 23228010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent Synthesis of Three Classes of Antifungal Amphiphilic Kanamycin Derivatives.
    Zhang Q; Alfindee MN; Shrestha JP; Nziko VP; Kawasaki Y; Peng X; Takemoto JY; Chang CT
    J Org Chem; 2016 Nov; 81(22):10651-10663. PubMed ID: 27715046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycodiversification for the optimization of the kanamycin class aminoglycosides.
    Wang J; Li J; Chen HN; Chang H; Tanifum CT; Liu HH; Czyryca PG; Chang CW
    J Med Chem; 2005 Oct; 48(20):6271-85. PubMed ID: 16190754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of glycodiversification: expedient synthesis and antibacterial evaluation of a library of kanamycin B analogues.
    Li J; Wang J; Czyryca PG; Chang H; Orsak TW; Evanson R; Chang CW
    Org Lett; 2004 Apr; 6(9):1381-4. PubMed ID: 15101747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective modification of the 3''-amino group of kanamycin prevents significant loss of activity in resistant bacterial strains.
    Santana AG; Zárate SG; Asensio JL; Revuelta J; Bastida A
    Org Biomol Chem; 2016 Jan; 14(2):516-525. PubMed ID: 26501183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of amphiphilic aminoglycoside-peptide triazole conjugates as antibacterial agents.
    Bera S; Zhanel GG; Schweizer F
    Bioorg Med Chem Lett; 2010 May; 20(10):3031-5. PubMed ID: 20413307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
    Fosso MY; Shrestha SK; Green KD; Garneau-Tsodikova S
    J Med Chem; 2015 Dec; 58(23):9124-32. PubMed ID: 26592740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
    Van Schepdael A; Delcourt J; Mulier M; Busson R; Verbist L; Vanderhaeghe HJ; Mingeot-Leclercq MP; Tulkens PM; Claes PJ
    J Med Chem; 1991 Apr; 34(4):1468-75. PubMed ID: 2016724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antibacterial activities of 1-N [(S)-omega-amino-2-hydroxyalkyl] kanamycin A derivatives.
    Richardson K; Jevons S; Moore JW; Ross BC; Wright JR
    J Antibiot (Tokyo); 1977 Oct; 30(10):843-6. PubMed ID: 591447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycoside antibiotics. 3. Epimino derivatives of neamine, ribostamycin, and kanamycin B.
    Kumar V; Jones GS; Blacksberg I; Remers WA; Misiek M; Pursiano TA
    J Med Chem; 1980 Jan; 23(1):42-9. PubMed ID: 6244410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships among the kanamycin aminoglycosides: role of ring I hydroxyl and amino groups.
    Salian S; Matt T; Akbergenov R; Harish S; Meyer M; Duscha S; Shcherbakov D; Bernet BB; Vasella A; Westhof E; Böttger EC
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6104-8. PubMed ID: 22948879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and antibacterial activity of a novel alkylide: 3-O-(3-aryl-propenyl)clarithromycin derivatives.
    Liang JH; Wang YY; Zhu DY; Dong LJ; An MM; Wang R; Yao GW
    J Antibiot (Tokyo); 2009 Nov; 62(11):605-11. PubMed ID: 19713989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuning the regioselectivity of the Staudinger reaction for the facile synthesis of kanamycin and neomycin class antibiotics with N-1 modification.
    Li J; Chen HN; Chang H; Wang J; Chang CW
    Org Lett; 2005 Jul; 7(14):3061-4. PubMed ID: 15987205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of guanidinylated neomycin B- and kanamycin A-derived amphiphilic lipid conjugates.
    Bera S; Zhanel GG; Schweizer F
    J Antimicrob Chemother; 2010 Jun; 65(6):1224-7. PubMed ID: 20332193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 4'-deoxy-4'-fluorokanamycin A and B.
    Takahashi Y; Tsuneda S; Tsuchiya T; Koyama Y; Umezawa S
    Carbohydr Res; 1992 Jul; 232(1):89-105. PubMed ID: 1423353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of kanamycin A analogs containing 6-amino-3-oxa-2,3,4,6-tetradeoxy-D- and -L-glycero-hexopyranose.
    Kuwahara R; Tsuchiya T
    Carbohydr Res; 1996 Jun; 286():107-22. PubMed ID: 8925510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
    Herzog IM; Louzoun Zada S; Fridman M
    J Med Chem; 2016 Sep; 59(17):8008-18. PubMed ID: 27509271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
    Kumar V; Remers WA
    J Med Chem; 1979 Apr; 22(4):432-6. PubMed ID: 107311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships for antibacterial to antifungal conversion of kanamycin to amphiphilic analogues.
    Fosso M; AlFindee MN; Zhang Q; Nziko Vde P; Kawasaki Y; Shrestha SK; Bearss J; Gregory R; Takemoto JY; Chang CW
    J Org Chem; 2015 May; 80(9):4398-411. PubMed ID: 25826012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and antibacterial activity of novel pleuromutilin derivatives bearing an amino thiazolyl ring.
    Ling Y; Wang X; Wang H; Yu J; Tang J; Wang D; Chen G; Huang J; Li Y; Zheng H
    Arch Pharm (Weinheim); 2012 Aug; 345(8):638-46. PubMed ID: 22532317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.